Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Chu NJ"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Zanvit P; Early Oncology Research., van Dyk D; Biologics Engineering., Fazenbaker C; Early Oncology Research., McGlinchey K; Early Oncology Research., Luo W; Early Oncology Research., Pezold JM; Early Oncology Research., Meekin J; Early Oncology Research., Chang CY; Biologics Engineering., Carrasco RA; Early Oncology Research., Breen S; Early Oncology Research., Cheung CS; Biologics Engineering., Endlich-Frazier A; Biologics Engineering., Clark B; Biologics Engineering., Chu NJ; Early Oncology Research., Vantellini A; Discovery Sciences, Oncology R&D, and., Martin PL; Oncology Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA., Hoover CE; Clinical Pathology Patient Safety, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Riley K; Clinical Pathology Patient Safety, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Sweet SM; Oncology Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA., Chain D; Oncology Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA., Kim YJ; Oncology Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA., Tu E; Oncology Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA., Harder N; Computational Pathology, AstraZeneca, Munich, Germany., Phipps S; Biologics Engineering., Damschroder M; Biologics Engineering., Gilbreth RN; Biologics Engineering., Cobbold M; Early Oncology Research., Moody G; Early Oncology Research., Bosco EE; Early Oncology Research.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2023 Nov 15; Vol. 133 (22). Date of Electronic Publication: 2023 Nov 15.
Autor:
Chu NJ; Department of Oncology, Skip Viragh Center for Pancreas Cancer, Bloomberg Kimmel Institute for Cancer Immunotherapy, and the Sidney Kimmel Cancer Center at Johns Hopkins University School of Medicine, Baltimore, Maryland., Anders RA; Department of Oncology, Skip Viragh Center for Pancreas Cancer, Bloomberg Kimmel Institute for Cancer Immunotherapy, and the Sidney Kimmel Cancer Center at Johns Hopkins University School of Medicine, Baltimore, Maryland.; Department of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland., Fertig EJ; Department of Oncology, Skip Viragh Center for Pancreas Cancer, Bloomberg Kimmel Institute for Cancer Immunotherapy, and the Sidney Kimmel Cancer Center at Johns Hopkins University School of Medicine, Baltimore, Maryland.; Department of Applied Mathematics and Statistics, Whiting School of Engineering, Johns Hopkins University, Baltimore, Maryland.; Department of Biomedical Engineering, Johns Hopkins School of Medicine, Baltimore, Maryland., Cao M; Department of Oncology, Skip Viragh Center for Pancreas Cancer, Bloomberg Kimmel Institute for Cancer Immunotherapy, and the Sidney Kimmel Cancer Center at Johns Hopkins University School of Medicine, Baltimore, Maryland., Hopkins AC; Department of Oncology, Skip Viragh Center for Pancreas Cancer, Bloomberg Kimmel Institute for Cancer Immunotherapy, and the Sidney Kimmel Cancer Center at Johns Hopkins University School of Medicine, Baltimore, Maryland., Keenan BP; Department of Oncology, Skip Viragh Center for Pancreas Cancer, Bloomberg Kimmel Institute for Cancer Immunotherapy, and the Sidney Kimmel Cancer Center at Johns Hopkins University School of Medicine, Baltimore, Maryland.; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California., Popovic A; Department of Oncology, Skip Viragh Center for Pancreas Cancer, Bloomberg Kimmel Institute for Cancer Immunotherapy, and the Sidney Kimmel Cancer Center at Johns Hopkins University School of Medicine, Baltimore, Maryland., Armstrong TD; Department of Oncology, Skip Viragh Center for Pancreas Cancer, Bloomberg Kimmel Institute for Cancer Immunotherapy, and the Sidney Kimmel Cancer Center at Johns Hopkins University School of Medicine, Baltimore, Maryland., Jaffee EM; Department of Oncology, Skip Viragh Center for Pancreas Cancer, Bloomberg Kimmel Institute for Cancer Immunotherapy, and the Sidney Kimmel Cancer Center at Johns Hopkins University School of Medicine, Baltimore, Maryland., Zimmerman JW; Department of Oncology, Skip Viragh Center for Pancreas Cancer, Bloomberg Kimmel Institute for Cancer Immunotherapy, and the Sidney Kimmel Cancer Center at Johns Hopkins University School of Medicine, Baltimore, Maryland. jzimme27@jhmi.edu.
Publikováno v:
Cancer prevention research (Philadelphia, Pa.) [Cancer Prev Res (Phila)] 2020 Jul; Vol. 13 (7), pp. 569-582. Date of Electronic Publication: 2020 May 14.
Autor:
Chu NJ; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland. Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland., Armstrong TD; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland., Jaffee EM; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland. Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland. ejaffee@jhmi.edu.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2015 Apr 01; Vol. 21 (7), pp. 1549-57. Date of Electronic Publication: 2015 Jan 26.